Use of CGM in Kidney Transplant Recipients
About this study
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
- Condition
- Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
- Tested
- Dexcom G6, Dexcom G6 blinded sensor
- Sponsor
- University of California, Davis
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
- Age 18 or above
- Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
- Person with Type 2 Diabetes and on insulin
- Access to home wi-fi connection
Exclusion 10
- Person with Type 1 Diabetes
- Patients taking hydroxyurea
- Patient unable to wear the Dexcom G6 device at all times for any reason
- Must be able to test blood glucose with meter 4x a day when on blinded CGM.
- Presence of clinically significant visual or cognitive impairment
- Illiterate
- Prisoners
- Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
- Presence of clinically unstable cardiovascular disease
- Active malignancy treatment
Where
1 site, 1 recruiting
UC Davis Health
Sacramento, California, United States
Contact
-
Dahlia Zuidema, PharmD
916-734-4009 dmzuidema@ucdavis.edu
-
Clinical Research Coordinators
916-734-4009 HS-TransplantCenterResearch@ucdavis.edu
Potential match only. Final eligibility is determined by the study team.